Inhibitors of sterol biosynthesis as Staphylococcus aureus antibiotics.
作者信息
Walsh Christopher T, Fischbach Michael A
机构信息
Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115, USA.
出版信息
Angew Chem Int Ed Engl. 2008;47(31):5700-2. doi: 10.1002/anie.200801801.
Abstract
摘要
相似文献
1
Inhibitors of sterol biosynthesis as Staphylococcus aureus antibiotics.
Angew Chem Int Ed Engl. 2008;47(31):5700-2. doi: 10.1002/anie.200801801.
2
Dual dehydrosqualene/squalene synthase inhibitors: leads for innate immune system-based therapeutics.
ChemMedChem. 2012 Apr;7(4):561-4. doi: 10.1002/cmdc.201100589. Epub 2012 Jan 30.
3
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
Science. 2008 Mar 7;319(5868):1391-4. doi: 10.1126/science.1153018. Epub 2008 Feb 14.
4
Genetics and molecular biology: a cholesterol-lowering drug with antibacterial properties.
Curr Opin Lipidol. 2008 Jun;19(3):324-5. doi: 10.1097/MOL.0b013e3282ff8630.
5
Removing the golden coat of Staphylococcus aureus.
N Engl J Med. 2008 Jul 3;359(1):85-7. doi: 10.1056/NEJMcibr0803278.
6
Golden pigment production and virulence gene expression are affected by metabolisms in Staphylococcus aureus.
J Bacteriol. 2010 Jun;192(12):3068-77. doi: 10.1128/JB.00928-09. Epub 2010 Apr 16.
7
Phosphonosulfonates are potent, selective inhibitors of dehydrosqualene synthase and staphyloxanthin biosynthesis in Staphylococcus aureus.
J Med Chem. 2009 Feb 26;52(4):976-88. doi: 10.1021/jm801023u.
8
Targeting isoprenoid biosynthesis for drug discovery: bench to bedside.
Acc Chem Res. 2010 Sep 21;43(9):1216-26. doi: 10.1021/ar100026v.
9
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.
J Med Chem. 2009 Jul 9;52(13):3869-80. doi: 10.1021/jm9001764.
10
Sterol composition and biosynthetic genes of the recently discovered photosynthetic alveolate, Chromera velia (chromerida), a close relative of apicomplexans.
J Eukaryot Microbiol. 2012 May-Jun;59(3):191-7. doi: 10.1111/j.1550-7408.2012.00611.x. Epub 2012 Feb 7.
引用本文的文献
1
Estragole Inhibits Growth and Aflatoxin Biosynthesis of by Affecting Reactive Oxygen Species Homeostasis.
Microbiol Spectr. 2023 Aug 17;11(4):e0134823. doi: 10.1128/spectrum.01348-23. Epub 2023 Jun 8.
2
Transcript Profiling of Nitroxoline-Treated Biofilms Shows Rapid Up-regulation of Iron Acquisition Gene Clusters.
ACS Infect Dis. 2022 Aug 12;8(8):1594-1605. doi: 10.1021/acsinfecdis.2c00206. Epub 2022 Jul 13.
3
Antibacterial and COX-2 Inhibitory Tetrahydrobisbenzylisoquinoline Alkaloids from the Philippine Medicinal Plant .
Plants (Basel). 2021 Mar 1;10(3):462. doi: 10.3390/plants10030462.
4
Staphylococcal response to oxidative stress.
Front Cell Infect Microbiol. 2012 Mar 16;2:33. doi: 10.3389/fcimb.2012.00033. eCollection 2012.
5
Functional expression and extension of staphylococcal staphyloxanthin biosynthetic pathway in Escherichia coli.
J Biol Chem. 2012 Jun 22;287(26):21575-83. doi: 10.1074/jbc.M112.343020. Epub 2012 Apr 25.
6
Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.
Antimicrob Agents Chemother. 2011 Jan;55(1):439-42. doi: 10.1128/AAC.00735-10. Epub 2010 Oct 11.
7
Defining the mode of action of tetramic acid antibacterials derived from Pseudomonas aeruginosa quorum sensing signals.
J Am Chem Soc. 2009 Oct 14;131(40):14473-9. doi: 10.1021/ja9056079.
8
Inhibition of staphyloxanthin virulence factor biosynthesis in Staphylococcus aureus: in vitro, in vivo, and crystallographic results.
J Med Chem. 2009 Jul 9;52(13):3869-80. doi: 10.1021/jm9001764.
本文引用的文献
1
A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence.
Science. 2008 Mar 7;319(5868):1391-4. doi: 10.1126/science.1153018. Epub 2008 Feb 14.
2
Invasive methicillin-resistant Staphylococcus aureus infections in the United States.
JAMA. 2007 Oct 17;298(15):1763-71. doi: 10.1001/jama.298.15.1763.
3
Emerging options for treatment of invasive, multidrug-resistant Staphylococcus aureus infections.
Pharmacotherapy. 2007 Feb;27(2):227-49. doi: 10.1592/phco.27.2.227.
4
Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress.
Infect Immun. 2006 Aug;74(8):4950-3. doi: 10.1128/IAI.00204-06.
5
Small-molecule inhibitor of Vibrio cholerae virulence and intestinal colonization.
Science. 2005 Oct 28;310(5748):670-4. doi: 10.1126/science.1116739. Epub 2005 Oct 13.
6
Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus.
J Biol Chem. 2005 Sep 16;280(37):32493-8. doi: 10.1074/jbc.M505070200. Epub 2005 Jul 14.
7
Crystal structure of human squalene synthase. A key enzyme in cholesterol biosynthesis.
J Biol Chem. 2000 Sep 29;275(39):30610-7. doi: 10.1074/jbc.M004132200.
8
Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway.
Annu Rev Biochem. 1999;68:157-85. doi: 10.1146/annurev.biochem.68.1.157.
Zotero 插件